Home Other Building Blocks 1,3-Dimethyluric acid

1,3-Dimethyluric acid

CAS No.:
944-73-0
Catalog Number:
AG0039GL
Molecular Formula:
C7H8N4O3
Molecular Weight:
196.1634
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
50mg
97%
1 week
United States
$126
- +
Product Description
Catalog Number:
AG0039GL
Chemical Name:
1,3-Dimethyluric acid
CAS Number:
944-73-0
Molecular Formula:
C7H8N4O3
Molecular Weight:
196.1634
MDL Number:
MFCD00009740
IUPAC Name:
1,3-dimethyl-7,9-dihydropurine-2,6,8-trione
InChI:
InChI=1S/C7H8N4O3/c1-10-4-3(8-6(13)9-4)5(12)11(2)7(10)14/h1-2H3,(H2,8,9,13)
InChI Key:
OTSBKHHWSQYEHK-UHFFFAOYSA-N
SMILES:
O=c1[nH]c2c([nH]1)c(=O)n(c(=O)n2C)C
EC Number:
213-410-1
UNII:
C222JTI9I3
NSC Number:
95854
Properties
Complexity:
386  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
196.06g/mol
Formal Charge:
0
Heavy Atom Count:
14  
Hydrogen Bond Acceptor Count:
3  
Hydrogen Bond Donor Count:
2  
Isotope Atom Count:
0
Molecular Weight:
196.166g/mol
Monoisotopic Mass:
196.06g/mol
Rotatable Bond Count:
0
Topological Polar Surface Area:
81.8A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
-0.5  
Literature
Title Journal
Effect of decursin on the pharmacokinetics of theophylline and its metabolites in rats. Journal of ethnopharmacology 20121121
Effect of decursinol angelate on the pharmacokinetics of theophylline and its metabolites in rats. Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association 20121001
Development and validation of a sensitive LC-MS/MS method for the simultaneous quantitation of theophylline and its metabolites in rat plasma. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20120315
Metabolite profiling of Angelica gigas from different geographical origins using 1H NMR and UPLC-MS analyses. Journal of agricultural and food chemistry 20110824
Development and validation of a LC-MS/MS method based on a new 96-well Hybrid-SPE™-precipitation technique for quantification of CYP450 substrates/metabolites in rat plasma. Analytical and bioanalytical chemistry 20110601
Usefulness of the simultaneous determination of serum levels of theophylline and its metabolites in patients medicated with theophylline preparation. Biomedical chromatography : BMC 20110401
Nanosized rods agglomerates as a new approach for formulation of a dry powder inhaler. International journal of nanomedicine 20110101
Nitrosation of N-methyl derivatives of uric acid and their transnitrosation ability to N-acetylcysteine. Chemical & pharmaceutical bulletin 20100901
Inhibition of CTP synthase from Escherichia coli by xanthines and uric acids. Bioorganic & medicinal chemistry letters 20100101
A synthetic uric acid analog accelerates cutaneous wound healing in mice. PloS one 20100101
Demethylation of theophylline (1,3-dimethylxanthine) to 1-methylxanthine: the first step of an antioxidising cascade. Redox report : communications in free radical research 20100101
Two distinct pathways for metabolism of theophylline and caffeine are coexpressed in Pseudomonas putida CBB5. Journal of bacteriology 20090701
Relaxing and contracting effects of theophylline's metabolites on the rabbit upper gastrointestinal tract. Fundamental & clinical pharmacology 20081001
Time-dependent effects of Klebsiella pneumoniae endotoxin (KPLPS) on the pharmacokinetics of theophylline in rats: return of the parameters in 96-hour KPLPS rats to the control levels. Drug metabolism and disposition: the biological fate of chemicals 20080501
[Population pharmacokinetic analysis of two theophylline formulations in premature neonates and infants with apnea]. Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan 20080401
Anti-inflammatory effect of theophylline in rats and its involvement of the glucocorticoid-glucocorticoid receptor system. Journal of pharmacological sciences 20080401
Effects of CYP inducers and inhibitors on the pharmacokinetics of intravenous theophylline in rats: involvement of CYP1A1/2 in the formation of 1,3-DMU. The Journal of pharmacy and pharmacology 20080101
Theophylline and its metabolites produce a stimulating cholinergic effect on the small intestine and a nonadrenergic noncholinergic relaxing effect on the colon: a comparative study in the rabbit intestine. Journal of veterinary pharmacology and therapeutics 20071201
Effects of water deprivation on the pharmacokinetics of theophylline and one of its metabolites, 1,3-dimethyluric acid, after intravenous and oral administration of aminophylline to rats. Biopharmaceutics & drug disposition 20071101
7-Arylpiperazinylalkyl and 7-tetrahydroisoquinolinylalkyl derivatives of 8-alkoxy-purine-2,6-dione and some of their purine-2,6,8-trione analogs as 5-HT(1A), 5-HT(2A), and 5-HT(7) serotonin receptor ligands. Bioorganic & medicinal chemistry 20070801
Lack of effect of aciclovir on metabolism of theophylline and expression of hepatic cytochrome P450 1A2 in rats. Biological & pharmaceutical bulletin 20070301
Associations between CYP2E1 promoter polymorphisms and plasma 1,3-dimethyluric acid/theophylline ratios. European journal of clinical pharmacology 20060801
Effect of a newly developed ketolide antibiotic, telithromycin, on metabolism of theophylline and expression of cytochrome P450 in rats. Life sciences 20060530
Microsphere-based protease assays and screening application for lethal factor and factor Xa. Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501
Liver dysfunction markedly decreases the inhibition of cytochrome P450 1A2-mediated theophylline metabolism by fluvoxamine. Clinical pharmacology and therapeutics 20060501
Pharmacokinetics of theophylline in diabetes mellitus rats: induction of CYP1A2 and CYP2E1 on 1,3-dimethyluric acid formation. European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 20050901
Methylated purines in urinary stones. Clinical chemistry 20050801
Theophylline pharmacokinetics: comparison of Cyp1a1(-/-) and Cyp1a2(-/-) knockout mice, humanized hCYP1A1_1A2 knock-in mice lacking either the mouse Cyp1a1 or Cyp1a2 gene, and Cyp1(+/+) wild-type mice. Pharmacogenetics and genomics 20050701
Inhibition of theophylline metabolism by suplatast and its metabolites in rats. Biological & pharmaceutical bulletin 20050601
Cytochrome P450 enzyme-mediated drug metabolism at exposure to acute hypoxia (corresponding to an altitude of 4,500 m). European journal of clinical pharmacology 20050301
Uric acid may inhibit glucose-induced insulin secretion via binding to an essential arginine residue in rat pancreatic beta-cells. Bioorganic & medicinal chemistry letters 20050215
High-throughput liquid chromatography-tandem mass spectrometry assay for plasma theophylline and its metabolites. Clinical chemistry 20041101
Separation, pre-concentration, and HPLC analysis of methylxanthines in urine samples. Journal of separation science 20041001
Catabolism of caffeine in plants and microorganisms. Frontiers in bioscience : a journal and virtual library 20040501
Pharmacokinetics of intravenous theophylline in mutant Nagase analbuminemic rats. Life sciences 20030131
Effects of acute renal failure induced by uranyl nitrate on the pharmacokinetics of intravenous theophylline in rats: the role of CYP2E1 induction in 1,3-dimethyluric acid formation. The Journal of pharmacy and pharmacology 20021201
Structural basis for the binding affinity of xanthines with the DNA intercalator acridine orange. Journal of medicinal chemistry 20011220
Effect of alosetron on theophylline pharmacokinetics. British journal of clinical pharmacology 20011101
Use of novel solid-phase extraction sorbent materials for high-performance liquid chromatography quantitation of caffeine metabolism products methylxanthines and methyluric acids in samples of biological origin. Journal of chromatography. B, Biomedical sciences and applications 20010815
Caffeine metabolism before and after liver transplantation. International journal of clinical pharmacology and therapeutics 20010201
Caffeine metabolism in a group of 67 patients with primary biliary cirrhosis. International journal of clinical pharmacology and therapeutics 20010101
Dose dependent pharmacokinetics of theophylline: Michaelis-Menten parameters for its major metabolic pathways. European journal of drug metabolism and pharmacokinetics 20010101
Neurotoxic convulsions induced by theophylline and its metabolites in mice. Biological & pharmaceutical bulletin 19960601
Structure-activity relationships for the binding of ligands to xanthine or guanine phosphoribosyl-transferase from Toxoplasma gondii. Biochemical pharmacology 19951109
Kinetics of drug action in disease states. XVI. Pharmacodynamics of theophylline-induced seizures in rats. The Journal of pharmacology and experimental therapeutics 19860301
Properties